147 related articles for article (PubMed ID: 36264549)
1. SPAG5 Activates PI3K/AKT Pathway and Promotes the Tumor Progression and Chemo-Resistance in Gastric Cancer.
An J; Yang L; Pan Y; He Y; Xie H; Tao Y; Li W; Yan Y; Chen S; Liu Y; Ma X; An L; Ji D; Su Z; Sheng J
DNA Cell Biol; 2022 Oct; 41(10):893-902. PubMed ID: 36264549
[TBL] [Abstract][Full Text] [Related]
2. SPAG5 promotes the proliferation, migration, invasion, and epithelial-mesenchymal transformation of colorectal cancer cells by activating the PI3K/AKT signaling pathway.
Zhang X; Wu W; Li X; He F; Zhang L
Chin J Physiol; 2023; 66(5):365-371. PubMed ID: 37929348
[TBL] [Abstract][Full Text] [Related]
3. Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway.
Li J; Ye D; Shen P; Liu X; Zhou P; Zhu G; Xu Y; Fu Y; Li X; Sun J; Xu J; Zhang Q
J Exp Clin Cancer Res; 2020 Oct; 39(1):212. PubMed ID: 33032635
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of STIL suppresses the progression of gastric cancer by down-regulating the IGF-1/PI3K/AKT pathway.
Wang J; Zhang Y; Dou Z; Jiang H; Wang Y; Gao X; Xin X
J Cell Mol Med; 2019 Aug; 23(8):5566-5575. PubMed ID: 31187582
[TBL] [Abstract][Full Text] [Related]
5. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma.
Yang YF; Zhang MF; Tian QH; Fu J; Yang X; Zhang CZ; Yang H
Mol Cancer; 2018 Aug; 17(1):117. PubMed ID: 30089483
[TBL] [Abstract][Full Text] [Related]
6. FOXD1-AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway.
Wu Q; Ma J; Wei J; Meng W; Wang Y; Shi M
Mol Oncol; 2021 Jan; 15(1):299-316. PubMed ID: 32460412
[TBL] [Abstract][Full Text] [Related]
7. A miR-567-PIK3AP1-PI3K/AKT-c-Myc feedback loop regulates tumour growth and chemoresistance in gastric cancer.
Zhang F; Li K; Yao X; Wang H; Li W; Wu J; Li M; Zhou R; Xu L; Zhao L
EBioMedicine; 2019 Jun; 44():311-321. PubMed ID: 31078520
[TBL] [Abstract][Full Text] [Related]
8. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S
Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766
[TBL] [Abstract][Full Text] [Related]
9. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
[TBL] [Abstract][Full Text] [Related]
10. SPAG5 contributes to the progression of gastric cancer by upregulation of Survivin depend on activating the wnt/β-catenin pathway.
Liu G; Liu S; Cao G; Luo W; Li P; Wang S; Chen Y
Exp Cell Res; 2019 Jun; 379(1):83-91. PubMed ID: 30904482
[TBL] [Abstract][Full Text] [Related]
11. LEM domain containing 1 promotes proliferation via activating the PI3K/Akt signaling pathway in gastric cancer.
Li Q; Ge Y; Chen X; Wang L; Xia Y; Xu Z; Li Z; Wang W; Yang L; Zhang D; Xu Z
J Cell Biochem; 2019 Sep; 120(9):15190-15201. PubMed ID: 31021450
[TBL] [Abstract][Full Text] [Related]
12. NUCKS1 promotes gastric cancer cell aggressiveness by upregulating IGF-1R and subsequently activating the PI3K/Akt/mTOR signaling pathway.
Huang YK; Kang WM; Ma ZQ; Liu YQ; Zhou L; Yu JC
Carcinogenesis; 2019 Apr; 40(2):370-379. PubMed ID: 30371738
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA hsa_circ_0010882 promotes the progression of gastric cancer via regulation of the PI3K/Akt/mTOR signaling pathway.
Peng YK; Pu K; Su HX; Zhang J; Zheng Y; Ji R; Guo QH; Wang YP; Guan QL; Zhou YN
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1142-1151. PubMed ID: 32096170
[TBL] [Abstract][Full Text] [Related]
14. SPAG5 as a novel biomarker and potential therapeutic target via regulating AKT pathway in multiple myeloma.
Zeng X; Xu W; Tong J; Liu J; Zhang Z; Liu M; Wu C; Yu Q; Ye C; Wu C; Wu Y; Yan H
Leuk Lymphoma; 2022 Nov; 63(11):2565-2572. PubMed ID: 35730922
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1.
Yan R; Li K; Yuan DW; Wang HN; Zhang Y; Dang CX; Zhu K
Int J Oncol; 2018 Dec; 53(6):2566-2578. PubMed ID: 30320337
[TBL] [Abstract][Full Text] [Related]
16. Annexin A1 induces oxaliplatin resistance of gastric cancer through autophagy by targeting PI3K/AKT/mTOR.
Ren J; Hu Z; Niu G; Xia J; Wang X; Hong R; Gu J; Wang D; Ke C
FASEB J; 2023 Mar; 37(3):e22790. PubMed ID: 36786694
[TBL] [Abstract][Full Text] [Related]
17. Dual PI3K/mTOR inhibitor PF-04979064 regulates tumor growth in gastric cancer and enhances drug sensitivity of gastric cancer cells to 5-FU.
Zhong Z; Wang T; Zang R; Zang Y; Feng Y; Yan S; Geng C; Zhu N; Wang Q
Biomed Pharmacother; 2024 Jan; 170():116086. PubMed ID: 38159377
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA circ_0006089 promotes the progression of gastric cancer by regulating the miR-143-3p/PTBP3 axis and PI3K/AKT signaling pathway.
Lin GR; Chen WR; Zheng PH; Chen WS; Cai GY
J Dig Dis; 2022 Jul; 23(7):376-387. PubMed ID: 35844201
[TBL] [Abstract][Full Text] [Related]
19. CLEC5A promotes the proliferation of gastric cancer cells by activating the PI3K/AKT/mTOR pathway.
Wang Q; Shi M; Sun S; Zhou Q; Ding L; Jiang C; Bian T; Jia F; Liu Y; Qin J
Biochem Biophys Res Commun; 2020 Apr; 524(3):656-662. PubMed ID: 32033754
[TBL] [Abstract][Full Text] [Related]
20. Notum enhances gastric cancer stem-like cell properties through upregulation of Sox2 by PI3K/AKT signaling pathway.
Liu Y; Chen H; Xiao L; Dong P; Ma Y; Zhou Y; Yang J; Bian B; Xie G; Chen L; Shen L
Cell Oncol (Dordr); 2024 Apr; 47(2):463-480. PubMed ID: 37749430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
